‘Pandora’s box’: FDA peptide votes could open the door to more unproven drugs

This version of Fda Peptide Votes Open Door Unproven Drugs Pandoras Box Rcna589105 - Health and Medicine | NBC News Clone was adapted by NBC News Clone to help readers digest key facts more efficiently.

An FDA panel with ties to the industry recommended loosening regulations on six peptides over objections from FDA scientists over a lack of data.

A hand wearing latex gloves hold a phial of clear liquid and a syringe. The medical professional uses the syringe to extract the medicine from the glass bottle.

Peptides have been for everything from faster healing to younger-looking skin and a longer lifespan, despite little evidence that they actually work and are safe. Getty Images file

July 24, 2026, 5:17 PM EDT

By Berkeley Lovelace Jr.

A Food and Drug Administration advisory committee on Friday recommended allowing two more unproven peptides to be compounded, capping a two-day meeting that raised questions about whether the agency was weakening the guardrails designed to keep untested drugs from reaching patients.

Just a moment.

We are getting your experience ready.

Related Articles